LCP
PFE icon

LGT Capital Partners’s Pfizer PFE Stock Holding History

LGT Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,973
Closed -$395K – 68
2015
Q1 		$395K Sell
11,973
-116
-1% -$3.69K 0.1% 64
2014
Q4 		$357K Buy
+12,089
New +$347K 0.09% 61

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LGT Capital Partners's PFE Position: Q2 2015 in Review

LGT Capital Partners sold out of Pfizer (PFE) in Q2 2015, closing a stake of 11,973 shares — an estimated $395K sold.

LGT Capital Partners first reported a position in PFE in Q4 2014 and held it in 2 quarters. The position peaked at $395K in Q1 2015. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • LGT Capital Partners reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • LGT Capital Partners sold 11,973 Pfizer shares in Q2 2015, an estimated $395K.
  • LGT Capital Partners first reported a position in Pfizer in Q4 2014 and held it in 2 quarters.
  • LGT Capital Partners's Pfizer position peaked at $395K in Q1 2015.
  • 1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on LGT Capital Partners's 13F filing for Q2 2015, filed 24 Jul 2015.